Compare GSK plc (GSK) vs iShares Semiconductor ETF (SOXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs iShares Semiconductor ETF — how do they compare? GSK plc trades at $52.69 (market cap $101.34B), while iShares Semiconductor ETF trades at $535.05. The key difference: GSK plc pays a 3.49% dividend while iShares Semiconductor ETF pays none. Which is the better fit depends on your goals.
| GSK | SOXX | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | Sector/Thematic |
52-Week High | $61.18 | $655.01 |
52-Week Low | $36.20 | $236.93 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
SOXX (iShares Semiconductor ETF) trades at $538.09, down 5.25% amid a semiconductor sector pullback after a strong 88.78% YTD gain. Technical indicators show bearish momentum with support at $511 and resistance at $554. The ETF provides concentrated exposure to 30 leading chipmakers, benefiting from AI-driven demand growth but facing cyclical volatility. Recent news highlights Michael Burry's short position and Bank of America labeling semiconductors as the 'most crowded trade ever' (The Motley Fool, 2026-07-16; 24/7 Wall Street, 2026-07-15).
Outlook: Near-term pressure from sector rotation and valuation concerns balances long-term AI growth potential. Risks include cyclical downturns, crowded positioning, and geopolitical tensions. The ETF remains a high-beta play on semiconductor innovation, suitable for investors tolerant of volatility seeking tech exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →
